These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. What does the ALSFRS-R really measure? A longitudinal and survival analysis of functional dimension subscores in amyotrophic lateral sclerosis. Rooney J; Burke T; Vajda A; Heverin M; Hardiman O J Neurol Neurosurg Psychiatry; 2017 May; 88(5):381-385. PubMed ID: 27888187 [TBL] [Abstract][Full Text] [Related]
29. The epidemiology of amyotrophic lateral sclerosis in Reggio Emilia, Italy. Bonvicini F; Vinceti M; Marcello N; Rodolfi R; Rinaldi M Amyotroph Lateral Scler; 2008 Dec; 9(6):350-3. PubMed ID: 18615339 [TBL] [Abstract][Full Text] [Related]
30. Epidemiologic Trends of Amyotrophic Lateral Sclerosis in Ireland, 1996-2021. McFarlane R; Peelo C; Galvin M; Heverin M; Hardiman O Neurology; 2023 Nov; 101(19):e1905-e1912. PubMed ID: 37748881 [TBL] [Abstract][Full Text] [Related]
31. Epidemiological time-trend of amyotrophic lateral sclerosis (ALS) over two decades: The French population-based register of ALS in Limousin (FRALim register). Luna J; Defressigne O; Erazo D; Lautrette G; Raymondeau-Moustafa M; Preux PM; Boumediene F; Couratier P Rev Neurol (Paris); 2022 Nov; 178(9):914-923. PubMed ID: 36163089 [TBL] [Abstract][Full Text] [Related]
32. Prognosis for patients with amyotrophic lateral sclerosis: development and validation of a personalised prediction model. Westeneng HJ; Debray TPA; Visser AE; van Eijk RPA; Rooney JPK; Calvo A; Martin S; McDermott CJ; Thompson AG; Pinto S; Kobeleva X; Rosenbohm A; Stubendorff B; Sommer H; Middelkoop BM; Dekker AM; van Vugt JJFA; van Rheenen W; Vajda A; Heverin M; Kazoka M; Hollinger H; Gromicho M; Körner S; Ringer TM; Rödiger A; Gunkel A; Shaw CE; Bredenoord AL; van Es MA; Corcia P; Couratier P; Weber M; Grosskreutz J; Ludolph AC; Petri S; de Carvalho M; Van Damme P; Talbot K; Turner MR; Shaw PJ; Al-Chalabi A; Chiò A; Hardiman O; Moons KGM; Veldink JH; van den Berg LH Lancet Neurol; 2018 May; 17(5):423-433. PubMed ID: 29598923 [TBL] [Abstract][Full Text] [Related]
33. Association between alcohol exposure and the risk of amyotrophic lateral sclerosis in the Euro-MOTOR study. D'Ovidio F; Rooney JPK; Visser AE; Manera U; Beghi E; Logroscino G; Vermeulen RCH; Veldink JH; van den Berg LH; Hardiman O; Chiò A; J Neurol Neurosurg Psychiatry; 2019 Jan; 90(1):11-19. PubMed ID: 30076269 [TBL] [Abstract][Full Text] [Related]
34. Effect modification of the association between total cigarette smoking and ALS risk by intensity, duration and time-since-quitting: Euro-MOTOR. Peters S; Visser AE; D'Ovidio F; Vlaanderen J; Portengen L; Beghi E; Chio A; Logroscino G; Hardiman O; Pupillo E; Veldink JH; Vermeulen R; van den Berg LH; J Neurol Neurosurg Psychiatry; 2020 Jan; 91(1):33-39. PubMed ID: 31434759 [TBL] [Abstract][Full Text] [Related]
35. Aggregation of neurologic and neuropsychiatric disease in amyotrophic lateral sclerosis kindreds: a population-based case-control cohort study of familial and sporadic amyotrophic lateral sclerosis. Byrne S; Heverin M; Elamin M; Bede P; Lynch C; Kenna K; MacLaughlin R; Walsh C; Al Chalabi A; Hardiman O Ann Neurol; 2013 Nov; 74(5):699-708. PubMed ID: 23836460 [TBL] [Abstract][Full Text] [Related]
36. Epidemiology and survival trends of motor neurone disease in Northern Ireland from 2015 to 2019. McCluskey G; Duddy W; Haffey S; Morrison K; Donaghy C; Duguez S Eur J Neurol; 2022 Mar; 29(3):707-714. PubMed ID: 34748676 [TBL] [Abstract][Full Text] [Related]
37. Prognostic categories for amyotrophic lateral sclerosis. Scotton WJ; Scott KM; Moore DH; Almedom L; Wijesekera LC; Janssen A; Nigro C; Sakel M; Leigh PN; Shaw C; Al-Chalabi A Amyotroph Lateral Scler; 2012 Oct; 13(6):502-8. PubMed ID: 22670880 [TBL] [Abstract][Full Text] [Related]
38. Population-based epidemiology of amyotrophic lateral sclerosis (ALS) in an ageing Europe--the French register of ALS in Limousin (FRALim register). Marin B; Hamidou B; Couratier P; Nicol M; Delzor A; Raymondeau M; Druet-Cabanac M; Lautrette G; Boumediene F; Preux PM; Eur J Neurol; 2014 Oct; 21(10):1292-300, e78-9. PubMed ID: 24909935 [TBL] [Abstract][Full Text] [Related]
39. Modeling delay to diagnosis for amyotrophic lateral sclerosis: under reporting and incidence estimates. Rocchetti I; Taruscio D; Pierannunzio D BMC Neurol; 2012 Dec; 12():160. PubMed ID: 23259505 [TBL] [Abstract][Full Text] [Related]
40. Incidence of amyotrophic lateral sclerosis before and during the COVID-19 pandemic: evidence from an 8-year population-based study in Central Italy based on healthcare utilization databases. Sopranzi FM; Faragalli A; Pompili M; Carle F; Gesuita R; Ceravolo MG Amyotroph Lateral Scler Frontotemporal Degener; 2024 Aug; 25(5-6):554-562. PubMed ID: 38557366 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]